11:30 - 12:00
Networking Hub

Glucose-lowering drugs and cardiovascular protection: an added benefit or a primary factor in the type 2 diabetes treatment choice?

In light of positive results from recent cardiovascular outcome trials in diabetes, this interactive session will discuss how to best manage the risk of cardiovascular events in people with type 2 diabetes, and debate the potential role of cardiologists in diabetes care.

Hosted by: